974 Results

People

  1. De Angelis
    De Angelis
  2. Yahalom
    Yahalom
  3. Abrey
    Abrey
  4. Zelenetz
    Zelenetz
  5. Perales
    Perales
  6. Horwitz
    Horwitz
  7. Schoder
    Schoder
  8. Moskowitz
    Moskowitz
  9. Noy
    Noy
  10. Portlock
    Portlock

Groups

  1. Department of Medicine (413)
  2. Hematologic Malignancies, Division of (317)
  3. Center for Hematologic Malignancies (307)
  4. Lymphoma (162)
  5. GSK Faculty (154)
  6. Survivorship Research (142)
  7. Tow Center for Developmental Oncology (TCDO) (139)
  8. Sloan Kettering Institute Faculty (133)
  9. Radiology, Department of (99)
  10. Population Sciences Research Program (94)
  1. "lymphoma"
Formats
  1. Journal Article (854)
  2. Review (54)
  3. Conference Paper (13)
  4. Editorial (13)
  5. Meeting Abstract (11)
  6. Research Letter (11)
  7. Book Section (9)
  8. Correspondence (4)
  9. Guidelines (3)
  10. Miscellaneous (2)
Groups
  1. Department of Medicine (413)
  2. Hematologic Malignancies, Division of (317)
  3. Center for Hematologic Malignancies (307)
  4. Lymphoma (162)
  5. GSK Faculty (154)
  6. Survivorship Research (142)

More Groups

People
  1. Lisa De Angelis (69)
  2. Joachim Yahalom (46)
  3. Lauren Abrey (41)
  4. Andrew Zelenetz (40)
  5. Miguel-Angel Perales (31)
  6. Steven Horwitz (28)

More People

Years
  1. 2025 (21)
  2. 2024 (43)
  3. 2023 (40)
  4. 2022 (38)
  5. 2021 (21)
  6. 2020 (36)

More Years

Publications
  1. Journal of Clinical Oncology (38)
  2. Cancer (36)
  3. Leukemia and Lymphoma (36)
  4. Blood (35)
  5. Biology of Blood and Marrow Transplantation (21)
  6. Annals of Oncology (19)

More Publications

Publishers
  1. Elsevier Inc. (127)
  2. Springer (68)
  3. Wiley Blackwell (64)
  4. Lippincott Williams & Wilkins (62)
  5. Nature Publishing Group (53)
  6. American Society of Clinical Oncology (45)

More Publishers

Results (974)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: Clinical perspective and significance
    Journal Article

    Boyiadzis, M. M.; Dhodapkar, M. V.; Brentjens, R. J.; Kochenderfer, J. N.; Neelapu, S. S.; Maus, M. V.; Porter, D. L.; Maloney, D. G.; Grupp, S. A.; Mackall, C. L.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor – T-cell therapy in B-cell non-Hodgkin lymphomas
    Journal Article

    Shah, N. N.; Nagle, S. J.; Torigian, D. A.; Farwell, M. D.; Hwang, W. T.; Frey, N.; Nasta, S. D.; Landsburg, D.; Mato, A.; June, C. H.; more...
    Cytotherapy (2018)

    Fulltext@MSK | Save
  • Outcomes of relapsed and refractory primary mediastinal (thymic) large B cell lymphoma treated with second-line therapy and intent to transplant
    Journal Article

    Vardhana, S.; Hamlin, P. A.; Yang, J.; Zelenetz, A.; Sauter, C. S.; Matasar, M. J.; Ni, A.; Yahalom, J.; Moskowitz, C. H.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death
    Journal Article

    Liu, Y.; Mondello, P.; Erazo, T.; Tannan, N. B.; Asgari, Z.; de Stanchina, E.; Nanjangud, G.; Seshan, V. E.; Wang, S.; Wendel, H. G.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2018)

    Fulltext@MSK | Save
  • STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: Results of a phase 1b trial
    Journal Article

    Reilley, M. J.; McCoon, P.; Cook, C.; Lyne, P.; Kurzrock, R.; Kim, Y.; Woessner, R.; Younes, A.; Nemunaitis, J.; Fowler, N.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Two-year-old female with EBV-positive diffuse large B-cell lymphoma and subsequent CNS involvement with neurolymphomatosis
    Journal Article

    Bjornard, K. L.; Leventaki, V.; Nichols, K. E.; Sandlund, J. T.; Prockop, S.; Ehrhardt, M. J.
    Pediatric Blood and Cancer (2018)

    Fulltext@MSK | Save
  • Second malignancies in patients with myeloproliferative neoplasms: A population-based cohort study of 9379 patients
    Journal Article

    Landtblom, A. R.; Bower, H.; Andersson, T. M. L.; Dickman, P. W.; Samuelsson, J.; Björkholm, M.; Kristinsson, S. Y.; Hultcrantz, M.
    Leukemia (2018)

    Fulltext@MSK | Save
  • Evidence for and against green tea and turmeric in the management of chronic lymphocytic leukemia
    Journal Article

    Bange, E.; Timlin, C.; Kabel, C.; Svoboda, J.; Roeker, L.; Mato, A. R.
    Clinical Lymphoma, Myeloma and Leukemia (2018)

    Fulltext@MSK | Save
  • Analytical validation of clinical whole-genome and transcriptome sequencing of patient-derived tumors for reporting targetable variants in cancer
    Journal Article

    Wrzeszczynski, K. O.; Felice, V.; Abhyankar, A.; Kozon, L.; Geiger, H.; Manaa, D.; London, F.; Robinson, D.; Fang, X.; Lin, D.; more...
    Journal of Molecular Diagnostics (2018)

    Fulltext@MSK | Save
  • Comprehensive safety analysis of venetoclax monotherapy for patients with relapsed/refractory chronic lymphocytic leukemia
    Journal Article

    Davids, M. S.; Hallek, M.; Wierda, W.; Roberts, A. W.; Stilgenbauer, S.; Jones, J. A.; Gerecitano, J. F.; Kim, S. Y.; Potluri, J.; Busman, T.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save